review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1036162331 |
P356 | DOI | 10.1038/NRC2675 |
P932 | PMC publication ID | 6059364 |
P698 | PubMed publication ID | 19609265 |
P2093 | author name string | G Paolo Dotto | |
P2860 | cites work | p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities | Q22003973 |
Human ligands of the Notch receptor | Q22009037 | ||
Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors | Q22010043 | ||
Behavioral alterations associated with apoptosis and down-regulation of presenilin 1 in the brains of p53-deficient mice | Q22254072 | ||
MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors | Q24290574 | ||
The p53 family member genes are involved in the Notch signal pathway | Q24291822 | ||
The notch regulator MAML1 interacts with p53 and functions as a coactivator | Q24298020 | ||
Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma | Q24301127 | ||
Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes | Q24307538 | ||
p53 isoforms can regulate p53 transcriptional activity. | Q24319034 | ||
The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells | Q24319096 | ||
Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint | Q24324057 | ||
Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing | Q24524157 | ||
p300 acts as a transcriptional coactivator for mammalian Notch-1 | Q24548267 | ||
Efficient tumour formation by single human melanoma cells | Q24648938 | ||
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors | Q24652007 | ||
Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3 | Q24672178 | ||
Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex | Q24675233 | ||
Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases | Q24680631 | ||
Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis | Q28143403 | ||
Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene | Q28143662 | ||
Mammalian Numb is a target protein of Mdm2, ubiquitin ligase | Q28184893 | ||
HES and HERP families: multiple effectors of the Notch signaling pathway | Q28205103 | ||
The role of p63 in development and differentiation of the epidermis | Q28241927 | ||
NUMB controls p53 tumour suppressor activity | Q28263413 | ||
miR-203 represses 'stemness' by repressing DeltaNp63 | Q28280357 | ||
Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation | Q28510156 | ||
IRF-7 is the master regulator of type-I interferon-dependent immune responses | Q28511410 | ||
Role of the Notch ligand Delta1 in embryonic and adult mouse epidermis | Q28512409 | ||
p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours | Q28513003 | ||
Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation | Q28572315 | ||
p63 regulates multiple signalling pathways required for ectodermal organogenesis and differentiation | Q28585767 | ||
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development | Q28587664 | ||
p63 is a p53 homologue required for limb and epidermal morphogenesis | Q28588206 | ||
Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway | Q28592687 | ||
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours | Q29547697 | ||
The canonical Notch signaling pathway: unfolding the activation mechanism | Q29547725 | ||
Notch signalling: a simple pathway becomes complex | Q29555851 | ||
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia | Q29614269 | ||
A global map of p53 transcription-factor binding sites in the human genome | Q29614400 | ||
Notch1 functions as a tumor suppressor in mouse skin | Q29614987 | ||
Network motifs: theory and experimental approaches | Q29615325 | ||
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas | Q29615658 | ||
Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome | Q29616850 | ||
Transcriptional control of human p53-regulated genes | Q29617650 | ||
Notch-1 regulates transcription of the epidermal growth factor receptor through p53. | Q30435514 | ||
From signals to patterns: space, time, and mathematics in developmental biology | Q33346156 | ||
The p53 family in differentiation and tumorigenesis. | Q53336172 | ||
The Biology of Ewing sarcoma. | Q53575285 | ||
Activated Notch1 interacts with p53 to inhibit its phosphorylation and transactivation. | Q53582142 | ||
A subset of p53-deficient embryos exhibit exencephaly | Q72031963 | ||
Wild-type human p53 activates the human epidermal growth factor receptor promoter | Q72351836 | ||
EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation | Q73959452 | ||
Acute effects of UVB radiation on the proliferation and differentiation of keratinocytes | Q78402946 | ||
C/EBPbeta participates in regulating transcription of the p53 gene in response to mitogen stimulation | Q79631231 | ||
Off the beaten pathway: the complex cross talk between Notch and NF-kappaB | Q80146628 | ||
The vertebrate segmentation clock | Q80355784 | ||
Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression | Q81066571 | ||
ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor | Q81249003 | ||
p53 regulation orchestrates the TGF-beta response | Q81355939 | ||
Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53 | Q83228672 | ||
Transcriptional regulation of the presenilin-1 gene: implication in Alzheimer's disease | Q36991946 | ||
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia | Q37009642 | ||
Identification of p53 regulators by genome-wide functional analysis | Q37073614 | ||
Sic transit gloria: farewell to the epidermal transit amplifying cell? | Q37121024 | ||
EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma | Q37135628 | ||
It's T-ALL about Notch | Q37256435 | ||
Notch tumor suppressor function | Q37256446 | ||
Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition | Q37258903 | ||
Oscillations by the p53-Mdm2 feedback loop | Q37265432 | ||
Recent advances in p53 research: an interdisciplinary perspective. | Q37273304 | ||
EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer | Q37355217 | ||
Differential recognition of response elements determines target gene specificity for p53 and p63 | Q38324246 | ||
Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. | Q39320608 | ||
Transcriptional cross talk between NF-kappaB and p53. | Q39445554 | ||
Notch signaling is necessary for epithelial growth arrest by TGF-beta | Q39733550 | ||
RBP-Jkappa binds to and represses transcription of the p53 tumor suppressor gene | Q39896991 | ||
The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia | Q39991646 | ||
Transcriptional activation of the human epidermal growth factor receptor promoter by human p53. | Q40020159 | ||
Notch1 activation reduces proliferation in the multipotent hematopoietic progenitor cell line FDCP-mix through a p53-dependent pathway but Notch1 effects on myeloid and erythroid differentiation are independent of p53. | Q40042294 | ||
Regulation of DeltaNp63alpha by tumor necrosis factor-alpha in epithelial homeostasis | Q40047420 | ||
Overexpressed active Notch1 induces cell growth arrest of HeLa cervical carcinoma cells | Q40147287 | ||
Notch1 induces cell cycle arrest and apoptosis in human cervical cancer cells: involvement of nuclear factor kappa B inhibition | Q40168062 | ||
A proline repeat domain in the Notch co-activator MAML1 is important for the p300-mediated acetylation of MAML1. | Q40171091 | ||
TAp73 isoforms antagonize Notch signalling in SH-SY5Y neuroblastomas and in primary neurones. | Q40213854 | ||
Growth suppression induced by Notch1 activation involves Wnt-beta-catenin down-regulation in human tongue carcinoma cells | Q40293810 | ||
p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis | Q40329606 | ||
Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation | Q40444094 | ||
p53 regulates thymic Notch1 activation | Q40584271 | ||
Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. | Q40606801 | ||
p21/CDKN1A mediates negative regulation of transcription by p53. | Q40647697 | ||
Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling | Q42475218 | ||
Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor kappaB activity | Q42480361 | ||
Impaired notch signaling promotes de novo squamous cell carcinoma formation | Q42499149 | ||
p53 homologue, p51/p63, maintains the immaturity of keratinocyte stem cells by inhibiting Notch1 activity | Q42507106 | ||
Defining the transcriptome of accelerated and replicatively senescent keratinocytes reveals links to differentiation, interferon signaling, and Notch related pathways | Q42678966 | ||
Notch activation suppresses fibroblast growth factor-dependent cellular transformation | Q42804897 | ||
Consequences of Notch-mediated induction of Jagged1. | Q42828884 | ||
Regulation of cancer stem cells by p53. | Q43249111 | ||
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism | Q43607424 | ||
The Notch pathway in podocytes plays a role in the development of glomerular disease | Q46725170 | ||
Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression | Q47852578 | ||
Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7. | Q51952187 | ||
Multiple roles of Notch signaling in the regulation of epidermal development. | Q51959619 | ||
MiRNA expression analysis during normal zebrafish development and following inhibition of the Hedgehog and Notch signaling pathways. | Q51982674 | ||
High-frequency developmental abnormalities in p53-deficient mice. | Q52206956 | ||
Mastermind is a putative activator for Notch. | Q52580782 | ||
Restoration of p53 expression in human cancer cell lines upregulates the expression of Notch1: implications for cancer cell fate determination after genotoxic stress | Q35812707 | ||
Notch in mammary gland development and breast cancer | Q35853093 | ||
Notch signaling in the integrated control of keratinocyte growth/differentiation and tumor suppression | Q35853114 | ||
Regulation of Notch1 gene expression by p53 in epithelial cells | Q35856917 | ||
A dynamic model of keratinocyte stem cell renewal and differentiation: role of the p21WAF1/Cip1 and Notch1 signaling pathways | Q35888270 | ||
DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2. | Q35901203 | ||
Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. | Q35913517 | ||
The strength of indecisiveness: oscillatory behavior for better cell fate determination | Q35991071 | ||
Epidermal growth factor receptor biology in head and neck cancer | Q36500973 | ||
The FoxO3a gene is a key negative target of canonical Notch signalling in the keratinocyte UVB response. | Q36632589 | ||
The multifaceted role of Notch in cancer | Q36687811 | ||
Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks | Q36688585 | ||
Control of keratinocyte proliferation and differentiation by p63. | Q36723013 | ||
Crossing paths with Notch in the hyper-network | Q36743025 | ||
Identification of tumor-initiating cells in a p53-null mouse model of breast cancer | Q36762011 | ||
The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions | Q36861078 | ||
Transcriptional regulation of the p53 tumor suppressor gene | Q33547809 | ||
Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation | Q33732463 | ||
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation | Q33733341 | ||
p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation | Q33855418 | ||
Skin cancer and solar UV radiation | Q33859295 | ||
The p53/p63/p73 family of transcription factors: overlapping and distinct functions. | Q33893917 | ||
Stimulation of human epidermal differentiation by delta-notch signalling at the boundaries of stem-cell clusters. | Q33901073 | ||
Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic). | Q33969345 | ||
Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation | Q34077697 | ||
Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression | Q34084509 | ||
Structure and function of IRF-7. | Q34114255 | ||
Alterations in Notch signaling in neoplastic lesions of the human cervix | Q34124673 | ||
DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development | Q34197318 | ||
Wnt-related molecules and signaling pathway equilibrium in hematopoiesis | Q34286624 | ||
Robustness of cellular functions | Q34348549 | ||
The epidemiology of UV induced skin cancer | Q34421835 | ||
LIN-12/Notch activation leads to microRNA-mediated down-regulation of Vav in C. elegans | Q34441379 | ||
The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene | Q34462232 | ||
Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA. | Q34501252 | ||
Overlapping and distinct mechanisms regulating IRF-3 and IRF-7 function | Q34532718 | ||
Mechanisms of cutaneous toxicities to EGFR inhibitors. | Q34567916 | ||
rugose (rg), a Drosophila A kinase anchor protein, is required for retinal pattern formation and interacts genetically with multiple signaling pathways | Q34615312 | ||
Three habits of highly effective signaling pathways: principles of transcriptional control by developmental cell signaling | Q34649230 | ||
A skin microRNA promotes differentiation by repressing 'stemness'. | Q34756894 | ||
Transcriptome-wide noise controls lineage choice in mammalian progenitor cells | Q34780848 | ||
The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations | Q34784078 | ||
A role for p53 in terminal epithelial cell differentiation | Q34790871 | ||
Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways. | Q34817672 | ||
A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. | Q34847034 | ||
c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma | Q34958884 | ||
Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus type 16 E6 and E7 oncogenes through a PI3K-PKB/Akt-dependent pathway | Q35020680 | ||
p63: Molecular complexity in development and cancer | Q35700466 | ||
p63 and the epithelial stem cell: more than status quo? | Q35705610 | ||
Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation | Q35787104 | ||
P433 | issue | 8 | |
P304 | page(s) | 587-595 | |
P577 | publication date | 2009-07-16 | |
P1433 | published in | Nature Reviews Cancer | Q641657 |
P1476 | title | Crosstalk of Notch with p53 and p63 in cancer growth control | |
P478 | volume | 9 |
Q37101911 | A miR-34a-SIRT6 axis in the squamous cell differentiation network |
Q38959215 | A new tumor suppressor role for the Notch pathway in bladder cancer |
Q34447293 | A novel anticancer therapy that simultaneously targets aberrant p53 and Notch activities in tumors |
Q34009814 | Activation of the Notch1 Stem Cell Signaling Pathway during Routine Cell Line Subculture |
Q42470016 | Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates |
Q90470329 | Autophagy promotes mammalian survival by suppressing oxidative stress and p53 |
Q37853267 | Calcineurin signaling as a negative determinant of keratinocyte cancer stem cell potential and carcinogenesis |
Q36173879 | Cancer associated human papillomaviruses |
Q42040176 | Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities. |
Q36068315 | Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15. |
Q35251799 | Cleaved NOTCH1 Expression Pattern in Head and Neck Squamous Cell Carcinoma Is Associated with NOTCH1 Mutation, HPV Status, and High-Risk Features |
Q33695197 | Clinical update on cancer: molecular oncology of head and neck cancer |
Q36425130 | Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation |
Q36322862 | Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma |
Q28256121 | Comprehensive genomic characterization of head and neck squamous cell carcinomas |
Q34427267 | Concomitant Notch activation and p53 deletion trigger epithelial-to-mesenchymal transition and metastasis in mouse gut. |
Q38064316 | Crossing paths in Human Renal Cell Carcinoma (hRCC). |
Q37619334 | Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation. |
Q34978948 | DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation |
Q34603835 | Deltex-1 activates mitotic signaling and proliferation and increases the clonogenic and invasive potential of U373 and LN18 glioblastoma cells and correlates with patient survival |
Q33815952 | Differential control of Notch1 gene transcription by Klf4 and Sp3 transcription factors in normal versus cancer-derived keratinocytes |
Q36129113 | Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17. |
Q55287292 | Double agents: genes with both oncogenic and tumor-suppressor functions. |
Q35914389 | Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ERα-ΔNp63-Integrin β4 Signaling Pathway |
Q91756685 | Genomic characterization of early-stage esophageal squamous cell carcinoma in a Japanese population |
Q50917827 | Genomic insights into head and neck cancer. |
Q37626853 | HEY1 functions are regulated by its phosphorylation at Ser-68. |
Q37462472 | High expression of the Notch ligand Jagged-1 is associated with poor prognosis after surgery for colorectal cancer |
Q35558846 | Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms. |
Q41897787 | IKK1 control of epidermal differentiation is modulated by notch signaling |
Q35626298 | IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes |
Q38207847 | Immune system modulation of kidney regeneration--mechanisms and implications. |
Q38940800 | Inferring the Effects of Honokiol on the Notch Signaling Pathway in SW480 Colon Cancer Cells |
Q36823573 | Inhibition of Notch Signaling During Mouse Incisor Renewal Leads to Enamel Defects |
Q54250476 | Inhibition of TGF-β and NOTCH Signaling by Cutaneous Papillomaviruses. |
Q37381036 | Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers |
Q40693934 | LGN plays distinct roles in oral epithelial stratification, filiform papilla morphogenesis and hair follicle development |
Q35527142 | Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression. |
Q64990535 | Manipulation of Epithelial Differentiation by HPV Oncoproteins. |
Q35830233 | Mathematical Modelling of Molecular Pathways Enabling Tumour Cell Invasion and Migration |
Q55438460 | Mesenchymal stem cell-mediated Notch2 activation overcomes radiation-induced injury of the hematopoietic system. |
Q33982509 | MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblasts |
Q34756505 | NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients |
Q37118737 | Negative control of CSL gene transcription by stress/DNA damage response and p53. |
Q37191199 | Nitric oxide-releasing sulindac is a novel skin cancer chemopreventive agent for UVB-induced photocarcinogenesis |
Q30557594 | Noncanonical NOTCH signaling limits self-renewal of human epithelial and induced pluripotent stem cells through ROCK activation |
Q92889973 | Notch and breast cancer metastasis: Current knowledge, new sights and targeted therapy |
Q39116742 | Notch as a tumour suppressor. |
Q33826808 | Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells |
Q37867484 | Notch signalling in solid tumours: a little bit of everything but not all the time |
Q41993883 | Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy. |
Q34086677 | Notch1 binds and induces degradation of Snail in hepatocellular carcinoma |
Q39561078 | Notch1 differentially regulates oncogenesis by wildtype p53 overexpression and p53 mutation in grade III hepatocellular carcinoma. |
Q28486035 | Notch1 is a 5-fluorouracil resistant and poor survival marker in human esophagus squamous cell carcinomas |
Q35269377 | Notch1 regulates the effects of matrix metalloproteinase-9 on colitis-associated cancer in mice. |
Q26783710 | Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors |
Q92860226 | Reciprocal Crosstalk Between YAP1/Hippo Pathway and the p53 Family Proteins: Mechanisms and Outcomes in Cancer |
Q36081663 | Signaling circuitries controlling stem cell fate: to be or not to be. |
Q36909843 | Squamous Cell Cancers: A Unified Perspective on Biology and Genetics |
Q36604651 | Stacking the DEK: from chromatin topology to cancer stem cells |
Q34786512 | Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma |
Q39063034 | Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives |
Q38838071 | Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives. |
Q41683685 | The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI. |
Q40411894 | The Varied Roles of Notch in Cancer |
Q37797944 | The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network |
Q36659339 | The molecular pathogenesis of head and neck squamous cell carcinoma |
Q38248780 | The p53 control of apoptosis and proliferation: lessons from Drosophila |
Q34020353 | The p53 orchestra: Mdm2 and Mdmx set the tone |
Q34907001 | The retinoid-related orphan receptor RORα promotes keratinocyte differentiation via FOXN1 |
Q36392179 | The transcription factor CREBZF is a novel positive regulator of p53. |
Q43007546 | The wind rose of human keratinocyte cell fate |
Q47302520 | Therapeutic Antibody Targeting Tumor- and Osteoblastic Niche-Derived Jagged1 Sensitizes Bone Metastasis to Chemotherapy |
Q88334763 | Unravelling disparate roles of NOTCH in bladder cancer |
Q36287442 | Vimentin regulates differentiation switch via modulation of keratin 14 levels and their expression together correlates with poor prognosis in oral cancer patients. |
Q93188568 | Wild-type TP53 defined gamma-secretase inhibitor sensitivity and synergistic activity with doxorubicin in GSCs |
Q34255543 | Xiaotan Sanjie decoction attenuates tumor angiogenesis by manipulating Notch-1-regulated proliferation of gastric cancer stem-like cells |
Q53218333 | [Malignancy potential of precursor lesions: determination using molecular markers]. |
Q34123719 | miR-122 regulates p53/Akt signalling and the chemotherapy-induced apoptosis in cutaneous T-cell lymphoma |
Q37428692 | miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma. |
Q47646348 | miR-34a is involved in CSE-induced apoptosis of human pulmonary microvascular endothelial cells by targeting Notch-1 receptor protein |
Q37727778 | p53-family proteins and their regulators: hubs and spokes in tumor suppression |
Q33649826 | sel-11 and cdc-42, two negative modulators of LIN-12/Notch activity in C. elegans |
Q64062966 | ΔNp63 in squamous cell carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour microenvironment |
Q28587251 | ΔNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation |
Q35557019 | ΔNp63α promotes cellular quiescence via induction and activation of Notch3. |
Q36234694 | α-Synuclein induces alterations in adult neurogenesis in Parkinson disease models via p53-mediated repression of Notch1. |